Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499096 · ClinicalTrials.gov registry record · Phase 3
Self-Management Addressing Heart Disease Risk Trial
A Phase 3 study of Bipolar Disorder and Cardiovascular Disease, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT00499096 is a Phase 3 study of Bipolar Disorder and Cardiovascular Disease that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 118 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00499096, a Phase 3 study of Bipolar Disorder and Cardiovascular Disease, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide self management and care management.
Conditions Studied
Interventions
- BEHAVIORAL Chronic care model for Bipolar Disorder
Study Locations (1)
Michigan
- VA Ann Arbor Healthcare System - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00499096
The ClinicalTrials.gov registry entry for NCT00499096 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Chronic care model for Bipolar Disorder is the first listed.
NCT00499096 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00499096 about?
NCT00499096 is a clinical study titled "Self-Management Addressing Heart Disease Risk Trial". The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide self management and care management.
What is the current status of trial NCT00499096?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 118 participants. The study started on 2008-05. Estimated completion is 2012-11.
What conditions does trial NCT00499096 study?
This clinical trial studies the following conditions: Bipolar Disorder, Cardiovascular Disease.
What interventions are being tested in trial NCT00499096?
The interventions under investigation include: Chronic care model for Bipolar Disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT00499096?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00499096 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RECRUITING · Phase 3
-
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RECRUITING · Phase 3
-
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
COMPLETED · Phase 3
-
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
COMPLETED · Phase 3
-
Acute Treatment of Bipolar II Depression
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.